Dermira Recognizes World Psoriasis Day

World Psoriasis Day is an annual day specially dedicated to people with psoriasis/psoriatic arthritis. Conceived by patients for patients, World Psoriasis Day, sponsored by the International Federation of Psoriasis Association, is a truly global event that sets out to give an international voice to the 125 million people with psoriasis/psoriatic arthritis.

TECHNOLOGY SPOTLIGHT

Cimzia®, our lead product candidate, is a PEGylated, humanized antigen-binding mAb fragment TNF inhibitor in development for the treatment of moderate-to-severe plaque psoriasis.

Dermira Prices Initial Public Offering

REDWOOD CITY, Calif., October 2, 2014 – Dermira, Inc. (NASDAQ: DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients, today announced the pricing of its initial public offering of 7,812,500 shares of common stock at a price to the public of $16.00 per share. The… View Article

Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients.